Should You Expect Rhythm Pharmaceuticals Inc (NASDAQ:RYTM) To Recover From Its 40.94% Gain From Highs?
Rhythm Pharmaceuticals Inc (NASDAQ:RYTM)’s traded shares stood at 0.68 million during the last session, with the company’s beta value hitting 2.29. At the close of